Chemical prevention or reversal of cataract by phase separation inhibitors
AssigneeMassachusetts Institute of Technology
InventorsJohn I. Clark, Geroge B. Benedek, Roelant J. Siezen, John A. Thomson, Simon H. Friedman
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods and pharmaceutical reagents for decreasing the phase separation temperature and inhibiting the formation of high molecular weight aggregates in eye lenses, thereby inhibiting or reversing cataract formation.
Claims2
A method for inhibiting cataractogenesis in an animal in need thereof, comprising administering to the animal a therapeutically or prophylactically effective amount of pantothenic acid.
A method for inhibiting cataractogenesis in an animal in need thereof, comprising administering to the animal a therapeutically or prophylactically effective amount of panthenol.
Dependencies are inferred from the claim text.